TO THE QUESTION OF DIAGNOSTICS AND WAYS OF CORRECTION OF THE DIABETIC MACROVASCULAR DISEASE OF THE LOWER EXTREMITIES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Diabetes mellitus remains one of the most pressing problems in the 21st century. The research objective was to study the level of glycotoxins and oxidation-reduction potential of a serum/cell at the complicated and uncomplicated course of diabetes mellitus type 2 was and find the ways to correct the disorder. Materials and methods. There were three groups of patients aged from 55 up to 70 years, a total of 80 people. The main group (group No. 3) was presented by 40 men suffering from a diabetes mellitus type 2 with a macrovascular disease of the lower extremities. Depending on the chosen remedy and the carried-out therapy, patients of the first group were sectioned into subgroups on 20 people, in the 2nd subgroup additionally N-acetylcysteine solution was introduced in a daily dose of 600 mg once, intravenously, within 7 days. Definition of the studied indicators was made by HPLS methods, prior to therapy, for the third and seventh day. Results. Obtained data confirm activation of polyol pathway of glucose disintegration. Antioxidant potential of the serum and cells decreases. Using N-acetylcysteini in complex therapy reduces implications of carbonyl and oxidative stresses, due to multiple decrease of the final products of glycation. Conclusions. When identifying the presented indicators in patients with diabetic macroangiopathy of the lower extremities, the administration of N-acetylcysteine, intravenously in a daily dose of 600 mg (7 days course) is recommended.

glyoxal, methylglyoxal, malondialdehyde, diabetes, complications of diabetes, cysteine, glutathione, antioxidant system

1. Дедов И.И. Алгоритмы специализированной медицинской помощи больным сахарным диабетом: клинические рекомендации. - М., 2017. - 8 с. Dedov II. (2015). Algorithms of specialized medical care for patients with diabetes: clinical guidelines [Algoritmy spetsializirovannoy meditsinskoy pomoshchi bol'nym sakhar-nym diabetom: klinicheskie rekomendatsii]. Moskva, 5 p.

2. Дутов А.А., Никитин Д.А. N-ацетилцистеин: фармакокинетические параметры и влияние на концентрацию эндогенных аминотиолов // Фармакокинетика и фармакодинамика. - 2016. - № 2. - С. 26-30. Dutov AA, Nikitin DA. (2016). N-acetylcysteine: the pharmacokinetic parameters and the effect on the concentration of endocannabinoids [N-atsetiltsistein: farmakokineticheskie parametry i vliyanie na kontsen-tratsiyu endogennykh aminotiolov]. Farmakokinetika i farmakodinamika, (2), 34-38.

3. Дутов А.А., Никитин Д.А., Ермолина А.В., Лукьянова Ю.Л., Шемякина Н.А. Простой ВЭЖХ метод анализа метилглиоксаля и глиоксаля в плазме // European Journal of Analytical and Applied Chemistry. - 2017. -№ 1. - С. 14-20. Dutov AA, Nikitin DA, Ermolina AV, Lukyanova YuL, Shemyakina NA. (2017). A simple HPLC method for analyzing glyoxal and methylglyoxal in plasma [Prostoy VEZhKh metod analiza metilglioksalya i glioksalya v plazme]. European Journal of Analytical and Applied Chemistry, (1), 14-20.

4. Титов В.Н., Ширяева Ю.К. Артериолосклероз и атеросклероз. Патология дистального и проксимального отделов артериального русла. Патогенез диабетической микроангиопатии // Клиническая лабораторная диагностика. - 2011. - № 4. - С. 3-14. Titov VN, Shiryaeva YuK. (2011). Arteriolosclerosis and atherosclerosis. Pathology of the distal and proximal arterial bed. The pathogenesis of diabetic microangiopathy [Arterioloskleroz i ateroskleroz. Patologiya distal’nogo i proksimal’nogo otdelov arterial’nogo rusla. Patogenez diabeticheskoy mikroangiopatii]. Klinicheskaya laboratornaya diagnostika, (4), 3-14.

5. Bloch-Damti A., Basham N. (2005). Proposed mechanisms for the induction of insulin resistance by oxidative stress. Antioxid Redox Signal, 7, 1553-1567.

6. Esterbauer H., Cheeseman К.Н. (1990). Determination of aldehydic lipid peroxidation products: malond-ialdehyde and 4-hydroxynonenal. Methods Enzymol, 186, 407-421.

7. Jones D.P. (2002). Redox potential of GSH/GSSG couple: assay and biological significance. Methods Enzymol, 348, 93-112.

8. Marnett L.J. (1999). Lipid peroxidation - DNA damage by malondialdehyde. Mutat Res, 424, 83-95.

9. Nair U., Bartsch H., Nair J. (2007). Lipid peroxidation-induced DNA damage in cancer-prone inflammatory diseases: a review of published adducts types and levels in humans. Free Radic Biol Med, 43 (8), 1109-1120.

10. Shangari N., O’Brien P.J. (2004). The cytotoxic mechanism of glyoxal involves oxidative stress. Biochem Pharmacol, 68 (7), 1433-1442.

11. Sugimoto K., Yasujima М., Yagihashi S. (2008). Role of advanced glycation end products in diabetic neuropathy. Curr Pharm Des, 14 (10), 953-961.

12. Thornalley P.J. (2007). Endogenous a-oxoaldehydes and formation of protein and nucleotide advanced glycationendproducts in tissue damage. Novartis Found Symp, 285, 229-246.

13. Turk Z. (2010). Glycotoxines, carbonyl stress and relevance to diabetes and its complications. Review. Physiol Res, 59 (2), 147-156.